Lung cancer combo therapy study halted before start

NCT ID NCT00210171

Terminated Disease control Sponsor: Institut Bergonié Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 14, 2026 · Updated 26 times

Summary

This study was designed for people with advanced non-small cell lung cancer that could not be removed by surgery. It planned to use a combination of chemotherapy drugs (cisplatin and docetaxel) along with radiation therapy to shrink tumors and control the disease. However, the study was withdrawn before any participants were enrolled, so no results are available.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARCINOMA, NON-SMALL-CELL LUNG are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Centre Hospitalier Universitaire de Bordeaux

Bordeaux, 33076, France
Centre de radiothérapie d'Agen

Agen, 47000, France
Clinique Francheville

Périgueux, 24000, France
Clinique Tivoli

Bordeaux, 33000, France
Hôpital Robert Boulin

Libourne, 33500, France
Institut Bergonié - Centre Régional de Luttre Contre le Cancer de Bordeaux et du Sud Ouest

Bordeaux, 33076, France
Polyclinique Bordeaux Nord

Bordeaux, 33000, France

Conditions

Explore the condition pages connected to this study.

CARCINOMA, NON-SMALL-CELL LUNG